Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Story

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
Trials|August 5, 2024
Correction: Can flash glucose monitoring improve glucose management for Aboriginal and Torres Strait Islander peoples with type 2 diabetes? A protocol for a randomised controlled trialMariam Hachem, Tracey Hearn, Ray Kelly, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2012
Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerabilityBilada Bilican, Andrea Serio, Sami J Barmada, et al.
Science Translational Medicine|June 7, 2013
Comment on "Drug screening for ALS using patient-specific induced pluripotent stem cells"Bilada Bilican, Andrea Serio, Sami J Barmada, et al.
Brain Communications|March 30, 2022
Transactive response DNA-binding protein-43 proteinopathy in oligodendrocytes revealed using an induced pluripotent stem cell modelSamantha K Barton, Dario Magnani, Owen G James, et al.
Nature Communications|January 11, 2022
Reactive astrocytes acquire neuroprotective as well as deleterious signatures in response to Tau and Aß pathologyZoeb Jiwaji, Sachin S Tiwari, Rolando X Avilés-Reyes, et al.
Nature Communications|January 26, 2018
C9ORF72 repeat expansion causes vulnerability of motor neurons to Ca<sup>2+</sup>-permeable AMPA receptor-mediated excitotoxicityBhuvaneish T Selvaraj, Matthew R Livesey, Chen Zhao, et al.
Nature Communications|August 28, 2023
Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseasesErik Nutma, Nurun Fancy, Maria Weinert, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
Trials|August 5, 2024
Correction: Can flash glucose monitoring improve glucose management for Aboriginal and Torres Strait Islander peoples with type 2 diabetes? A protocol for a randomised controlled trialMariam Hachem, Tracey Hearn, Ray Kelly, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2012
Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerabilityBilada Bilican, Andrea Serio, Sami J Barmada, et al.
Science Translational Medicine|June 7, 2013
Comment on "Drug screening for ALS using patient-specific induced pluripotent stem cells"Bilada Bilican, Andrea Serio, Sami J Barmada, et al.
Brain Communications|March 30, 2022
Transactive response DNA-binding protein-43 proteinopathy in oligodendrocytes revealed using an induced pluripotent stem cell modelSamantha K Barton, Dario Magnani, Owen G James, et al.
Nature Communications|January 11, 2022
Reactive astrocytes acquire neuroprotective as well as deleterious signatures in response to Tau and Aß pathologyZoeb Jiwaji, Sachin S Tiwari, Rolando X Avilés-Reyes, et al.
Nature Communications|January 26, 2018
C9ORF72 repeat expansion causes vulnerability of motor neurons to Ca<sup>2+</sup>-permeable AMPA receptor-mediated excitotoxicityBhuvaneish T Selvaraj, Matthew R Livesey, Chen Zhao, et al.
Nature Communications|August 28, 2023
Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseasesErik Nutma, Nurun Fancy, Maria Weinert, et al.
Pageof 11